Carlson Capital Management’s ImmunityBio IBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	$51.2K	Buy	20,000 +1,000	+5%	+$2.56K	﹤0.01%	111
2024 Q3	$70.7K	Buy	19,000 +390	+2%	+$1.45K	﹤0.01%	114
2024 Q2	$118K	Buy	18,610 +810	+5%	+$5.12K	0.01%	105
2024 Q1	$95.6K	Buy	17,800 +200	+1%	+$1.07K	﹤0.01%	101
2023 Q4	$88.4K	Buy	+17,600	New	+$88.4K	﹤0.01%	201